Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from crushresearch.shop, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|
| Cagrilintide | 1 | 99.69% | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| Double Agonist | 2 | 99.95% | — | — |
| EPITALON | 1 | 99.08% | — | — |
| GHK-Cu | 1 | 99.91% | — | — |
| Klow | 1 | 99.47% | — | — |
| KPV | 1 | 99.36% | — | — |
| MOTS-c | 1 | 99.91% | — | — |
| NAD+ | 2 | 99.22% | — | — |
| PT-141 | 1 | 99.93% | — | — |
| Tesamorelin | 1 | 99.47% | — | — |
| Triple Agonist | 2 | 99.77% | — | — |
| VIP | 1 | 99.46% | — | — |
| MOTS-c | CR-MTS10-0309-1 | ILS Labs | 99.91% | LALUSP<71>HM | 2026-05-11 | View |
| Tesamorelin | CR-TSM20-0307-1 | ILS Labs | 99.47% | LALUSP<71>HM | 2026-05-11 | View |
| EPITALON | CRET-50-0212-1 | ILS Labs | 99.08% | LALUSP<71>HM | 2026-05-11 | View |
| NAD 500mg | CRNAD-500-2604-2 | ILS Labs | 99.00% | LALUSP<71>HM | 2026-04-22 | View |
| Klow | CRKLO-80-2604-1 | ILS Labs | 99.47% | LALUSP<71>HM | 2026-04-22 | View |
| Double Agonist | CRTZ-30-2604-1 | ILS Labs | 99.95% | LALUSP<71>HM | 2026-04-22 | View |
| Double Agonist | CRTZ-30-2604-2 | ILS Labs | 99.95% | LALUSP<71>HM | 2026-04-22 | View |
| KPV | CRKPV-10-2604-1 | ILS Labs | 99.36% | LALUSP<71>HM | 2026-04-22 | View |
| GHK-Cu | CRGHK-100-2604-1 | ILS Labs | 99.91% | LALUSP<71>HM | 2026-04-22 | View |
| Cagrilintide | CRCAG-5-2604-1 | ILS Labs | 99.69% | LALUSP<71>HM | 2026-04-22 | View |
| Triple Agonist | CRRT-30-2604-2 | ILS Labs | 99.92% | LALUSP<71>HM | 2026-04-22 | View |
| VIP | CRVIP-10-2604-1 | ILS Labs | 99.46% | LALUSP<71>HM | 2026-04-22 | View |
| Retatrutide | CR-3XAG14-2604-1 | ILS Labs | 99.61% | LALUSP<71>HM | 2026-04-04 | View |
Disclosed Labs